Neuromyelitis optica: a pilot study of clinical presentation and status of serological biomarker AQP4 among patients admitted to a tertiary centre in NCNS, Sudan

BACKGROUND: Neuromyelitis optica (NMO) is a demyelinating disease primarily affecting the optic nerves and spinal cord. It is distinguished from other demyelinating conditions by the presence of AQP4-IgG and serum aquaporin 4 (AQP4), found mainly in the blood–brain barrier. This descriptive study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Etedal Ahmed AbuElbasher, Gammer, Fatima, Gassoum, Alsadig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048117/
https://www.ncbi.nlm.nih.gov/pubmed/32111161
http://dx.doi.org/10.1186/s12868-020-0557-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048117/
https://www.ncbi.nlm.nih.gov/pubmed/32111161
http://dx.doi.org/10.1186/s12868-020-0557-x

Ejemplares similares